tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Tong Ren Tang Technologies Delays Circular Dispatch for Transaction Renewals

Story Highlights
  • Tong Ren Tang Technologies Co. is a Chinese pharmaceutical company specializing in traditional medicine.
  • The company announced a delay in dispatching a circular for transaction renewals, now expected by November 30, 2025.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Tong Ren Tang Technologies Delays Circular Dispatch for Transaction Renewals

Meet Your ETF AI Analyst

Tong Ren Tang Technologies Co ( (HK:1666) ) just unveiled an announcement.

Tong Ren Tang Technologies Co. announced a delay in the dispatch of a circular related to the renewal of continuing connected transactions under the Distribution Framework Agreement and the Master Procurement Agreement. The delay, which pushes the dispatch date to on or before November 30, 2025, is due to the additional time needed to finalize the circular’s details and arrange its publication.

The most recent analyst rating on (HK:1666) stock is a Hold with a HK$5.50 price target. To see the full list of analyst forecasts on Tong Ren Tang Technologies Co stock, see the HK:1666 Stock Forecast page.

More about Tong Ren Tang Technologies Co

Tong Ren Tang Technologies Co. is a joint stock company incorporated in the People’s Republic of China, operating within the pharmaceutical industry. The company is known for its production and distribution of traditional Chinese medicine products.

Average Trading Volume: 1,483,320

Technical Sentiment Signal: Strong Sell

Current Market Cap: HK$6.1B

Learn more about 1666 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1